NEW YORK (Reuters) - Life sciences company Bayer AG (BAYGn.DE) said on Friday it would discontinue the sale of its birth control product Essure in the United States, citing a decline in sales of the ...

A permanent birth-control implant called Essure will need to be labeled with a stronger warning that lists potentially serious risks of the device, the Food and Drug Administration announced this week ...

Federal health regulators plan to warn consumers more strongly about Essure, a contraceptive implant that has drawn thousands of complaints from women reporting chronic pain, bleeding and other health ...

WASHINGTON, D.C. (WPVI) -- A local congressman says the FDA grossly underestimated the harm caused by a contraceptive device. And he alleges the maker paid doctors kickbacks to recommend the device to ...

New surveillance data on women implanted with the ESSURE female sterilization device -- removed from the market in December 2018 -- confirm that substantial numbers suffer abnormal uterine bleeding ...

Five months after convening an advisory committee meeting to discuss concerns about the safety of Essure, the only non-surgical permanent contraceptive, the Food and Drug Administration on Monday ...

Tens of thousands of women say they suffered painful and serious side-effects from Essure, a medical device meant as a permanent birth control option. The device is the subject of nearly 27,000 ...

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. WASHINGTON — The maker of a permanent ...

Essure is a permanent birth control device that consists of two small metal coils inserted through the vagina into the fallopian tubes (see image, below). The device is popular among women and ...

Even though it’s no longer on the market, new data has emerged around potential side effects of the permanent birth control device Essure. The device, pulled from the US market two years ago amid ...